Showing results (2201-2210 of 2,821) with videos related to
Sort By:
Pageof 283
Depression and Anxiety|October 5, 2016
Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical TrialsWilliam A Carlezon, Andrew D KrystalDepression and Anxiety|March 19, 2019
Trajectories of childhood adversity and the risk of depression in young adulthood: Results from the Avon Longitudinal Study of Parents and ChildrenMelissa Tracy, Madeleine Salo, Natalie Slopen, et al.Depression and Anxiety|February 23, 2021
Neurocognitive mechanisms of poor social connection in posttraumatic stress disorder: Evidence for abnormalities in social working memoryLauren M Sippel, Paul E Holtzheimer, Jeremy F Huckins, et al.Depression and Anxiety|February 23, 2021
The contribution of early adverse stress to complex and severe depression in depressed outpatientsSergio Gloger, Paul A Vöhringer, Pablo Martínez, et al.Depression and Anxiety|February 22, 2021
Development and validation of a machine learning-based postpartum depression prediction model: A nationwide cohort studyEldar Hochman, Becca Feldman, Abraham Weizman, et al.Depression and Anxiety|March 1, 2017
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature reviewMaria M Steenkamp, Esther M Blessing, Isaac R Galatzer-Levy, et al.Depression and Anxiety|August 7, 2019
Apolipoprotein E gene polymorphism, posttraumatic stress disorder, and cognitive function in older U.S. veterans: Results from the National Health and Resilience in Veterans StudyLynnette A Averill, Chadi G Abdallah, Daniel F Levey, et al.Depression and Anxiety|June 6, 1998
Psychostimulant augmentation of second generation antidepressants: a case seriesP S Masand, V S Anand, J F TanquaryDepression and Anxiety|May 23, 1998
Efficacy of mirtazapine in clinically relevant subgroups of depressed patientsD J NuttDepression and Anxiety|May 23, 1998
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapineJ R Owen, C B NemeroffPageof 283